LLY

1,036.37

-0.35%↓

JNJ

243.49

+0.08%↑

ABBV

232.69

+0.55%↑

NVS

166.17

+2.06%↑

MRK

121.6

+0.22%↑

LLY

1,036.37

-0.35%↓

JNJ

243.49

+0.08%↑

ABBV

232.69

+0.55%↑

NVS

166.17

+2.06%↑

MRK

121.6

+0.22%↑

LLY

1,036.37

-0.35%↓

JNJ

243.49

+0.08%↑

ABBV

232.69

+0.55%↑

NVS

166.17

+2.06%↑

MRK

121.6

+0.22%↑

LLY

1,036.37

-0.35%↓

JNJ

243.49

+0.08%↑

ABBV

232.69

+0.55%↑

NVS

166.17

+2.06%↑

MRK

121.6

+0.22%↑

LLY

1,036.37

-0.35%↓

JNJ

243.49

+0.08%↑

ABBV

232.69

+0.55%↑

NVS

166.17

+2.06%↑

MRK

121.6

+0.22%↑

Search

Quanterix Corp

Uždarymo kaina

SektoriusSveikatos priežiūra

5.73 -0.17

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

5.59

Max

5.87

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-3.5M

-34M

Pardavimai

16M

40M

Pelno marža

-83.479

Darbuotojai

471

EBITDA

5.7M

-31M

Rekomendacijos

By TipRanks

Rekomendacijos

Neutralu

12 mėnesių prognozė

+30.66% upside

Dividendai

By Dow Jones

Kitas uždarbis

2026-03-16

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

30M

268M

Ankstesnė atidarymo kaina

5.9

Ankstesnė uždarymo kaina

5.73

Naujienos nuotaikos

By Acuity

50%

50%

165 / 351 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Neutral Evidence

Quanterix Corp Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-02-17 23:44; UTC

Karštos akcijos

Stocks to Watch: La-Z-Boy, Palo Alto Networks, Caesars

2026-02-17 23:20; UTC

Uždarbis

Palo Alto Networks Lifts FY26 Revenue Outlook as 2Q Profit Jumps -- Update

2026-02-17 22:57; UTC

Uždarbis

Santos Fiscal Year Net Profit Falls 33%, Nears Start of Alaska Project

2026-02-17 21:59; UTC

Uždarbis

Palo Alto Networks Lifts FY26 Revenue Outlook as 2Q Profit Jumps

2026-02-17 23:54; UTC

Rinkos pokalbiai

Nikkei May Rise as Fears About AI Disruption Ease -- Market Talk

2026-02-17 23:54; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2026-02-17 23:54; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-02-17 23:45; UTC

Rinkos pokalbiai

Suncorp's Outperformance of IAG Could Be Hard to Sustain -- Market Talk

2026-02-17 23:19; UTC

Uždarbis

Palo Alto's Guidance Overshadows Strong Earnings. Its Stock Is Down. -- Barrons.com

2026-02-17 23:15; UTC

Uždarbis

Palo Alto's Guidance Overshadows Strong Earnings. Its Stock Is Down. -- Barrons.com

2026-02-17 22:58; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Netflix Would Operate Warner's Studios, HBO Largely the Same -- Market Talk

2026-02-17 22:58; UTC

Įsigijimai, susijungimai, perėmimai

BlueScope Steel: Board Committed to Optimizing Value For Shareholders

2026-02-17 22:57; UTC

Įsigijimai, susijungimai, perėmimai

BlueScope Steel to Consider Revised SGH, Steel Dynamics Takeover Bid

2026-02-17 22:50; UTC

Įsigijimai, susijungimai, perėmimai

Agnico-Eagle Mines Acquired 662,780 Common Shrs of Maple Gold Mines at C$2.45 Per Common Shr >AEM.T

2026-02-17 22:44; UTC

Uždarbis

Palo Alto Reports Strong Earnings. Its Stock Is Down. -- Barrons.com

2026-02-17 22:42; UTC

Uždarbis

Santos FY Net Profit Falls 33%, Nears Start of Alaska Project

2026-02-17 22:36; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Netflix Sarandos: Paramount Causing Confusion Around Warner Deal -- Market Talk

2026-02-17 22:36; UTC

Uždarbis

Santos Final Dividend 10.3 U.S. Cents/Security

2026-02-17 22:36; UTC

Uždarbis

Santos FY Underlying Profit US$898 Million, Down 25%

2026-02-17 22:35; UTC

Uždarbis

Santos FY Revenue US$4.94 Billion, Down 8%

2026-02-17 22:35; UTC

Uždarbis

Correct: Santos FY Net Profit US$818 Million, Down 33%

2026-02-17 22:35; UTC

Įsigijimai, susijungimai, perėmimai

Berkshire Buys New York Times Stock; Sells Apple, Bank of America, Amazon In 4Q -- Barrons.com

2026-02-17 22:34; UTC

Uždarbis

Santos FY Net Profit US$818 Billion, Down 33%

2026-02-17 22:02; UTC

Įsigijimai, susijungimai, perėmimai

Berkshire Pares Stakes in Apple and BofA, Adds New York Times Position -- Update

2026-02-17 21:50; UTC

Įsigijimai, susijungimai, perėmimai

Steel Dynamics: SGH Would Buy BlueScope, On-sell North American Operations to SDI, As Earlier Proposed

2026-02-17 21:50; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Tech, Media & Telecom Roundup: Market Talk

2026-02-17 21:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2026-02-17 21:49; UTC

Įsigijimai, susijungimai, perėmimai

Steel Dynamics Says Revised Proposal Continues to Present Highly Strategic Opportunity For SDI Shareholders

2026-02-17 21:48; UTC

Įsigijimai, susijungimai, perėmimai

Steel Dynamics: BlueScope Offer a 56% Premium to 52-Week Volume Weighted Average Price

2026-02-17 21:48; UTC

Įsigijimai, susijungimai, perėmimai

Steel Dynamics: Consideration To Be Comprised Entirely of Cash

Akcijų palyginimas

Kainos pokytis

Quanterix Corp Prognozė

Kainos tikslas

By TipRanks

30.66% į viršų

12 mėnesių prognozė

Vidutinis 7.5 USD  30.66%

Aukščiausias 8 USD

Žemiausias 7 USD

Remiantis 2 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Quanterix Corp kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Neutralu

2 ratings

0

Pirkti

2

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

5.34 / 6.015Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Neutral Evidence

Vidutinės trukmės periodas

Bullish Evidence

Ilgalaikis periodas

No Evidence

Rinkos nuotaikos

By Acuity

165 / 351 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Aukščiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
help-icon Live chat